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KEYWORDS	
	 The	 complexing	 properties	 of	 2‐(aminomethyl)‐benzimidazole	 with	 cadmium(II)	 were
investigated	 pH‐metrically	 at	 25	 oC	 and	 at	 ionic	 strength	 of	 0.1	mol.dm‐3	 (NaNO3).	 Ternary
complex	 formation	 equilibria	 of	 cadmium(II)	 complexes	 involving	 (AMBI)	 and	 some	 bio‐
relevant	ligands	(L	=	amino	acid	and	peptides)	have	been	investigated.	Ternary	complexes	of
amino	 acids	 and	 peptides	 are	 formed	 by	 a	 simultaneous	mechanism.	Amino	 acids	 form	 the
complex	 Cd(AMBI)L,	 whereas	 amides	 form	 two	 complex	 species	 Cd(AMBI)L	 and
Cd(AMBI)(LH‐1).	 The	 stability	 of	 ternary	 complexes	was	 quantitatively	 compared	with	 their
corresponding	binary	complexes	in	terms	of	the	parameters	ΔLog	K,	Log	βStat	and	Log	X.	The
effect	of	the	side	chains	of	amino	acid	ligands	(ΔR)	on	complex	formation	was	discussed.	The
values	 of	 ΔLog	 K	 indicate	 that	 the	 ternary	 complexes	 containing	 aromatic	 amino	 acids	 are
significantly	more	 stable	 than	 the	complexes	 containing	alkyl‐	 and	hydroxyalkyl‐substituted
amino	acids.	This	may	be	taken	as	evidence	 for	a	stacking	interaction	between	the	aromatic
moiety	 of	 AMBI	 and	 the	 aromatic	 side	 chains	 of	 the	 bioactive	 ligands.	 The	 concentration
distributions	 of	 various	 species	 formed	 in	 solution	were	 also	evaluated	 as	 a	 function	of	pH.
The	 thermodynamic	 parameters	 ΔHo,	 ΔGo	 and	 ΔSo	 calculated	 from	 the	 temperature
dependence	of	the	equilibrium	constants	were	investigated	for	the	interaction	of	Cd(II)‐AMBI
with	glycine	as	a	representative	example	of	amino	acids.	
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1.	Introduction	
	
Ternary	 complexes	 formed	 between	 metal	 ions	 and	 two	
different	 types	 of	 bioactive	 ligands,	 namely	 heteroaromatic	
nitrogen	 bases	 and	 amino	 acids	 (or	 peptides)	 may	 be	
considered	 as	 models	 for	 substrate‐metal	 ion‐enzyme	
interactions	 and	 other	 metal	 ion	 mediated	 biochemical	
interactions	 [1].	 Kinetic	 analysis	 did	 show	 that	 the	 ternary	
complex	 involving	 amino	 acids	plays	 an	 important	 role	 in	 the	
exchange	 and	 transfer	 of	metal	 ions	 between	 amino	 acid	 and	
albumin	 [2].	 Recently,	 benzimidazole	 derived	 drugs	 have	
received	much	 attention	owing	 to	 the	 fact	 that	 benzimidazole	
residue	is	a	constituent	of	vitamin	B12	[3]	which	supports	their	
potential	 use	 as	 therapeutics	 [4].	 The	 great	 majority	 of	 the	
work	of	biological	chemists	is	concerned	with	the	coordination	
chemistry	 of	 essential	metal	 ions	 in	 living	 organisms;	 and	 the	
examination	 of	 aspects	 of	 the	 interactions	 of	 these	 essential	
metal	 ions	with	 the	 rest	 of	 the	 enzymes	 of	 the	 cells	 in	which	
they	are	 found.	The	present	 study	however	 is	 concerned	with	
the	 manipulation	 of	 the	 coordination	 environment	 of	 toxic	
metal	 ions	 in	 order	 to	 accelerate	 their	 excretion	 from	 the	
organism.	 The	 toxicology	 of	 Cd(II)	 is	 often	 governed	 by	 its	
interaction	with	 an	 abundance	 of	 certain	 potential	 ligands	 in	
biological	 system	 [5‐7].	 In	 animals,	 Cd(II)	 accumulates	mainly	
in	the	Liver	and	kidney,	where	it	is	largely	bound	to	thionine,	a	
sulfur‐rich	protein	[8].	In	red	blood	cells,	Cd(II)	is	complexed	by	
glutathione	 and	 hemoglobin	 [9].	 The	 goal	 of	 chelating	 agents	
treatment	 of	 metal	 intoxication	 is	 to	 transform	 a	 toxic	 metal	
bound	to	a	constituent	(usually	a	protein)	of	a	living	organism	
into	 a	 less	 toxic	 metal	 chelate	 which	 is	 readily	 excreted.	 In	
discussing	chelating	agent	design	it	was	reported	that	stability	
constant	 has	 been	 long	 recognized	 as	 a	 key	 factor	 in	 the	
determination	 of	 the	 chelating	 agent	 ability	 to	 remove	 the	
metal	 from	 living	 organism	 [10].	 Also,	 chelating	 agents	 that	
bear	a	charge	‐2	or	more,	such	as	the	antidotes	EDTA	and	2,3‐
dimercaptopropanol,	 are	 not	 able	 to	 pass	 through	 cellular	
membranes	to	an	appreciable	extent.	With	this	 in	mind	and	in	
the	 course	 of	 the	 search	 for	 a	 new	 antidote	 for	 Cd(II),	 2‐
aminomethylbenzimidazole	 (AMBI)	 was	 electrically	 neutral	
and	 found	 to	 form	 extremely	 stable	 complex	 with	 Cd(II)	 ion.	
Also,	the	choice	of	2‐aminomethylbenzimidazole	was	due	to	the	
fact	 that	 compounds	 containing	 this	 heterocycle	 have	 been	
shown	 to	 exhibit	 a	 broad	 spectrum	 of	 pharmacological	
activities	 [11].	 They	 include	 a	 variety	 of	 antifungal	 [12],	
antibacterial	 [13,14],	 antimicrobial	 [15],	 antiamobeic	 [16],	
antiparasitic	[17]	and	antitumor	[18].	Clinical	examples	include	
mebendazole	 and	 albendazole	 (antihelmintics)	 [19].	 The	
antiviral	 activity	 of	 some	 2‐substituted	 benzimidazole	
derivatives	 considered	 to	be	 related	 to	 their	 ability	 to	 chelate	
trace	metal	 ions	 in	biological	systems	[20].	Additionally,	AMBI	
possesses	 two	 aromatic	 rings	 and	 one	 of	 them	 contains	 basic	
nitrogen	 (imidazole)	 and	 possesses	 ‐accepting	 properties,	
which	 are	 expected	 to	display	 a	 stability‐enhancement	 due	 to	
the	hydrophobic	 interaction	with	 the	substituted	group	of	 the	
amino	 acids	 or	 involved	 in	 the	 aromatic	 ring	 ‐	 stacking	
effects	 with	 purine	 and	 pyrimidine	 bases.	 Hence,	 it	 seems	
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therefore	to	be	of	considerable	interest	to	study	the	formation	
equilibria	 of	 Cd(II)‐AMBI	 complex	 and	 to	 investigate	 its	
interaction	 with	 other	 ligands	 commonly	 exist	 in	 biological	
fluids	 (amino	 acids	 and	 peptides).	 The	 parameters	 generally	
used	 for	 indicating	 the	 stabilization	 of	 the	 mixed	 complexes	
with	respect	to	the	binary	ones	were	also	discussed.	
	
2.	Experimental	
	
2.1.	Materials	and	reagents		
		
2‐(Aminomethyl)‐benzimidazole.2HCl	 (AMBI)	 was	
obtained	 from	 the	 Aldrich	 Chem.	 Co.	 These	 ligands:	 glycine,	
alanine,	 valine,	 ‐phenylalanine,	 threonine,	 1,1‐cyclobutane	
dicarboxylic	 acid,	 aspartic	 acid,	 methionine,	 histamine.2HCl,	
histidine.HCl,	 glycinamide,	 glycyl‐glycine,	 glutamine	 together	
with	methylamine	hydrochloride	were	provided	by	 the	 Sigma	
Chem.	 Co.	 CdCl2.2H2O	 were	 provided	 by	 BDH.	 Carbonate‐free	
NaOH	 (titrant)	 was	 prepared	 and	 standardized	 against	
potassium	 hydrogen	 phthalate	 solution.	 All	 solutions	 were	
prepared	in	deionized	H2O.	
	
2.2.	Instrumentations		
	
Potentiometric	measurements	were	made	using	a	Metrohm	
686	titroprocessor	equipped	with	a	665	Dosimat	(Switzerland‐
Herisau).	A	 thermostatted	glass‐cell	equipped	with	a	magnetic	
stirring	 system,	 a	 Metrohm	 glass	 electrode,	 a	 thermometric	
probe,	a	microburet	delivery	tube	and	a	salt	bridge	connected	
with	 the	 reference	cell	 filled	with	0.1	mol.dm‐3	KCl	solution	 in	
which	 saturated	 calomel	 electrode	 was	 dipped	 are	 used.	
Temperature	 was	 maintained	 constant	 inside	 the	 cell	 at	
25.0±0.02	 oC,	by	 the	circulating	water	by	a	 thermostated	bath	
(precision	 ±	 0.02).	 The	 titroprocessor	 and	 electrode	 were	
calibrated	 daily	 with	 standard	 buffer	 solutions,	 potassium	
hydrogen	phthalate	(pH	=	4.008)	and	a	mixture	of	KH2PO4	and	
Na2HPO4	 (pH	 =	 6.865).	 All	 titrations	 were	 carried	 out	 at	
25.0±0.1	 oC,	 in	 a	 double‐walled	 glass	 cell,	 through	 the	 outer	
jacket	 of	 which	 water	 was	 circulated	 from	 a	 constant	
temperature	bath.		
	
2.3.	Procedure	and	measurements	
	
The	 following	 mixtures	 were	 prepared	 and	 titrated	
potentiometrically	with	0.05	M	NaOH	solution	at	constant	ionic	
strength	of	0.1	mol.dm‐3	NaNO3.	
a) 40	mL	of	solution	containing	1.25x10‐3	mol.dm‐3	Cd(II)	
ion;		
b) 40	mL	of	solution	containing	1.25x10‐3	mol.dm‐3	ligand	
(AMBI,	amino	acid	and	peptide);	
c) 40	mL	of	solution	containing	1.25x10‐3	mol.dm‐3	Cd(II)	
ion,	1.25x10‐3	mol.dm‐3	and	ligand	(AMBI);	
d) 40	mL	of	solution	containing	1.25x10‐3	mol.dm‐3	Cd(II)	
ion,	2.5x10‐3	mol.dm‐3	ligand	(amino	acid	and	peptide);	
e) 40	mL	of	solution	containing	1.25x10‐3	mol.dm‐3	Cd(II)	
ion,	 1.25x10‐3	 mol.dm‐3	 AMBI,	 1.25x10‐3	 mol.dm‐3	 and	
ligand	(amino	acid	or	peptide).	
The	 hydrolysis	 constants	 of	 CdII	 were	 determined	 by	
titrating	mixture	 (A).	 The	 proton	 association	 constants	 of	 the	
ligands	 were	 determined	 potentiometrically	 by	 titrating	
mixture	 (B).	The	 stability	 constants	of	 the	binary	Cd(II)‐AMBI	
complexes	 were	 determined	 by	 titrating	 mixture	 (C).	 The	
formation	 constants	 of	 Cd(II)‐L	 (L	 =	 amino	 acid	 and	 peptide)	
were	 determined	 by	 titrating	 mixture	 (D).	 The	 stability	
constants	 of	 the	 mixed‐ligand	 complexes	 of	 amino	 acids	 and	
peptides	were	determined	using	potentiometric	data	obtained	
from	mixture	 (E).	 Furthermore,	 the	 stability	 constants	 of	 the	
ternary	 complexes	 involving	 amino	 acids	 were	 determined	
using	 potentiometric	 data	 obtained	 from	 mixtures	 of	 CdII	
(1.25x10‐3	 M),	 AMBI	 and	 the	 amino	 acid	 solutions	 in	 a	
concentration	ratio	of	1:1:1,	1:2:1	and	1:1:2.	All	titrations	were	
performed	 in	a	purified	N2	atmosphere,	using	aqueous	0.05	M	
NaOH	as	titrant.	
The	pH	meter	 readings	were	converted	 into	hydrogen	 ion	
concentration	 by	 titrating	 a	 standard	 acid	 solution	 (0.05	
mol.dm‐3)	with	standard	base	solution	(0.05	mol.dm‐3)	at	25	oC	
and	I	=	0.1	mol.dm‐3	NaNO3.	The	pH	is	plotted	against	p[H].	The	
relationship	 pH	 ‐	 p[H]	 =	 0.05	was	 observed.	 [OH‐]	 value	 was	
calculated	using	a	pKw	value	of	13.921	[21].		
The	general	four	component	equilibrium	can	be	written	as	
follows	(charges	are	omitted	for	simplicity).	
	
l(Cd)	+	p(AMBI)	+	q(L)	+	r	(H)	⇌	(Cd)l(AMBI)p(L)q(H)r	 (1)	
	
l p q r
lpqr l p q r
Cd AMBI L H
β
Cd AMBI L H
	 	 	 (2)		
	
2.4.	Data	processing	
	
The	calculations	were	obtained	from	ca.	100	data	points	in	
each	titration	using	the	computer	program	MINIQUAD‐75	[22].	
The	 stoichiometry	 and	 stability	 constants	 of	 the	 complexes	
formed	 were	 determined	 by	 trying	 various	 possible	
composition	 models.	 The	 model	 selected	 gave	 the	 best	
statistical	 fit	 and	was	 chemically	 consistent	with	 the	 titration	
data	without	giving	any	systematic	drifts	 in	 the	magnitudes	of	
various	 residuals,	 as	 described	 elsewhere	 [22].	 The	 fitted	
model	was	tested	by	comparing	the	experimental	titration	data	
points	 and	 the	 theoretical	 curve	 calculated	 from	 the	values	of	
the	acid	dissociation	 constant	of	 the	 ligand	and	 the	 formation	
constants	of	 the	 corresponding	complexes.	The	MINIQUAD‐75	
program	actually	computes	the	overall	stability	constants.	The	
stepwise	 constants	 were	 then	 obtained	 accordingly.	 The	
species	distribution	diagrams	were	obtained	using	the	program	
SPECIES	[23]	under	the	experimental	condition	employed.		
	
3.	Results	and	discussion	
	
3.1.	Protonation	equilibria	of	AMBI	and	its	binary	complex	
formation	equilibria		
	
AMBI	 was	 titrated	 in	 the	 presence	 and	 absence	 of	 Cd(II)	
ion.	 The	 titration	 curve	 (Figure	 1)	 of	 the	 Cd(II)	 complex	was	
lowered	 from	 that	 of	 AMBI	 curve.	 This	 indicates	 a	 complex	
formation	 associated	 with	 release	 of	 hydrogen	 ions.	 The	
titration	data	as	calculated	for	Cd(II)	ions	and	AMBI,	taking	into	
consideration	 all	 feasible	 theoretical	 models	 were	 compared	
with	 those	 experimentally	 obtained.	 The	 equilibrium	patterns	
were	 chosen	 so	 as	 to	 lie	 between	 the	 observed	 and	 the	
calculated	data	applying	accurate	 statistical	 analysis	 involving	
the	 sum	 of	 squares	 of	 residuals.	 At	 this	 point,	 all	 protonation	
constants	 were	 kept	 constant,	 and	 the	 computer	 program	
MINIQUAD	was	applied	 for	 a	 second	 stage	of	 refinement.	 The	
whole	titration	data	obtained	fitted	with	different	composition	
models	 and	 the	 selected	 model	 with	 best	 statistical	 fit	 was	
found	to	consist	of	1:1	and	1:2	complexes	as	shown	in	Scheme	
1.		
This	 model	 was	 tested	 by	 comparing	 the	 experimental	
titration	data	points	and	 the	 theoretical	curve	calculated	 from	
the	values	of	acid	dissociation	constants	of	AMBI	and	formation	
constants	of	 the	Cd2+	 complex.	The	good	 fit	 is	 an	 indication	of	
the	 validity	 of	 the	 complex.	 The	 corresponding	 stability	
constants	are	Log	K1	=	4.56	and	Log	K2	=	3.98	i.e.	the	successive	
stability	 constants	 of	 the	 binary	 complexes	 decrease	 in	
accordance	with	statistical	expectation.	The	(Log10	K1‐Log10	K2)	
value	 is	 usually	 positive,	 since	 the	 coordination	 sites	 of	 the	
metal	 ions	 are	 more	 freely	 available	 for	 binding	 of	 the	 first	
molecule	than	the	second	one.	
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Scheme	1
	
	
The	formation	constants	of	M(II)‐complexes	of	bivalent	3d	
transition	 metal	 ions	 with	 AMBI	 are	 in	 the	 order:	 Cd2+	 (Log	
K[Cd(AMBI)(Gly)]	 =	 9.20)	 <	 Zn2+	 (Log	 K[Zn(AMBI)(Gly)]	 =	 13.50)	 [24]	 <	
Cu2+	 (Log	 K[Cu(AMBI)(Gly)]	 =	 16.67)	 [25].	 Thus,	 the	 Irving‐
Williams’order	 [26]	 of	 complexation	 which	 is	 related	 to	 the	
ligand‐field	 stabilization	 energy	 is	 full	 field.	 In	 general,	 it	 is	
noted	 that	 the	 stability	 constant	 of	 the	 Cu2+	 complex	 is	 quite	
large	 compared	 to	 the	 other	metals.	 The	 ligand	 field	will	 give	
Cu2+	some	extra	stabilization	due	to	tetragonal	distortion	of	the	
octahedral	symmetry	[27].	
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Figure	1.	Potentiometric	titration	curve	of	Cd‐AMBI	system.
	
	
3.2.	Ternary	complex	formation	equilibria		
	
Depending	on	the	chelating	ability	of	the	two	ligands	AMBI	
and	 the	 other	 ligand	 (L),	 the	 ternary	 complex	 formation	may	
proceeds	 through	 either	 a	 step‐wise	 or	 simultaneous	
mechanism.	 The	 formation	 constants	 of	 the	 binary	 Cd(II)‐L	
complexes	are	given	in	Table	1.	The	formation	constants	of	the	
binary	 cadmium(II)	 complexes	 with	 AMBI	 and	 the	 other	
selected	 bio‐ligands	 were	 found	 to	 be	 of	 the	 same	 order.	
Consequently,	 the	 ligation	 of	 AMBI	 and	 the	 other	 ligands	
mentioned	will	occur	simultaneously	according	to	the	following	
equilibrium	(3),	charges	are	omitted	for	simplicity.	
	
Cd	+	AMBI	+	L	⇌	Cd(AMBI)L			 	 	 (3)	
	
The	 overall	 formation	 constants	 values	 expressed	 as	 Log	
β1110	 given	 in	 Table	 1	 were	 calculated	 considering	 the	 acid	
dissociation	constants	of	the	ligands	and	formation	constants	of	
the	binary	complexes	as	known	quantities.		
	
3.2.1.	Ternary	complex	formation	equilibria	involving	amino	
acids	
	
The	 titration	 data	 of	 the	 ternary	 complexes	 with	 amino	
acids	and	AMBI	fit	satisfactorily	with	formation	of	the	species:	
Cd(AMBI),	 Cd(AMBI)2,	 Cd(L),	 Cd(L)2	 and	 Cd(AMBI)(L).	 The	
stability	 constant	 of	 Cd(AMBI)‐amino	 acid	 systems	 is	 larger	
than	 those	 for	 the	 corresponding	 monodentate	 methylamine	
complexes.	This	indicates	that	the	amino	acids	are	coordinating	
as	bidentate	ligands	through	the	amino	and	carboxylate	groups	
(Scheme	2).	
	
(1110)
O
O
CH2
NH2
N
HN
NH2
Cd
(1110)
N
HN
NH2
OH2
Cd
NH-CH3
 
	
Scheme	2	
	
Evidence	 for	 formation	 of	 mixed	 ligand	 complex	 by	
simultaneous	 mechanism	 was	 further	 verified	 by	 the	 good	
agreement	observed	between	 the	observed	and	 the	calculated	
data.		
Threonine	has	an	extra	binding	centre	on	the	β‐alcoholate	
group.	 This	 group	 was	 reported	 [28,29]	 to	 participate	 in	
transition	metal	ion	complex‐formation	reactions.	The	titration	
curve	for	the	threonine	complex	is	much	lower	than	the	curves	
for	 the	 other	 amino	 acid	 complexes	 in	 the	 region	 followed	by	
the	 complete	 formation	 of	 the	 (1110)	 complex.	 Also,	 the	
potentiometric	data	are	fitted	much	better	when	the	formation	
of	 the	 complex	 species	 with	 stoichiometric	 coefficients	 1110	
and	111‐1	 is	assumed.	Therefore,	 threonine	forms,	 in	addition	
to	 the	 previously	 mentioned	 complexes	 the	 Cd(AMBI)(LH‐1)	
species.	 The	 latter	 complex	 is	 formed	 through	 induced	
ionization	 of	 the	 β‐alcoholato	 group,	 as	 mentioned	 in	 the	
literature	[28,29].		
Aspartic	acid	has	one	amino	and	two	carboxylic	groups	as	
potential	chelating	centers.	It	may	coordinate	either	via	the	two	
carboxylate	groups	or	by	the	amino	and	one	carboxylate	group.	
The	 stability	 constant	 of	 the	 aspartic	 acid	 complex	 is	 in	 the	
range	of	those	for	amino	acids.	
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Table	1.	Stability	constants	of	binary	and	ternary	species	in	the	Cd(II)‐AMBI‐amino	acid	systems	25	oC	and	0.1	mol.dm‐3	ionic	strength	using	NaNO3.	
System	 l	 p	 q r	a Log	β S	b	
Cd(H2O)62+	 1	 0	 0 ‐1 ‐9.11±0.07 3.6	x	10‐6	
1	 0	 0	 ‐2	 ‐18.57±0.06	 	
AMBI	 0	 1	 0 1 7.86±0.04 4.8	x	10‐7	
0	 1	 0 2 11.11±0.05 	
1	 1	 0 0 4.56±0.07 1.6	x	10‐7	
1	 2	 0 0 8.54±0.06 	
Glycine	 0	 0	 1 1 9.71±0.02	 3.1	x	10‐7	
0	 0	 1 2 11.99±0.03 	
1	 0	 1 0 4.38±0.01	 2.2	x	10‐8	
1	 0	 2 0 8.02±0.02 	
1	 1	 1 0 9.20±0.09 2.1	x	10‐7	
Alanine	 0	 0	 1 1 9.69±0.01 9.2	x	10‐8	
0	 0	 1 2 11.88±0.02 	
1	 0	 1 0 4.19±0.03 4.6	x	10‐9	
1	 0	 2 0 7.62±0.01 	
1	 1	 1 0 9.01±0.08 1.0	x	10‐6	
Phenylalanine	 0	 0	 1	 1		 9.12±0.01	 8.0	x	10‐8	
0	 0	 1 2 11.01±0.03 	
1	 0	 1 0 3.98±0.03 7.3	x	10‐7	
1	 0	 2 0 7.01±0.04 	
1	 1	 1 0 9.56±0.09 2.8	x	10‐6	
Valine	 0	 0	 1 1	 9.57±0.01 9.9	x	10‐8	
0	 0	 1 2 11.70±0.03 	
1	 0	 1 0 3.95±0.05 2.3	x	10‐7	
1	 0	 2 0 7.05±0.04 	
1	 1	 1 0 9.11±0.06 1.5	x	10‐6	
Threonine	 0	 0	 1	 1	 9.06±0.01	 7.9	x	10‐8	
0	 0	 1 2 11.03±0.02 	
1	 0	 1 0 4.02±0.04 1.3	x	10‐9	
1	 0	 2 0 7.29±0.05 	
1	 1	 1 0 8.52±0.08 3.1	x	10‐7	
1	 1	 1 ‐1 3.29±0.1 	
Histamine	 0	 0	 1	 1	 9.88±0.01	 2.4	x	10‐8	
0	 0	 1 2 15.97±0.03 	
1	 0	 1 0 4.75±0.06 3.9	x	10‐7	
1	 0	 2 0 7.91±0.07 	
1	 1	 1 0 10.15±0.05 	
1	 1	 1 1 17.89±0.03 4.5	x	10‐7	
Histidine	 0	 0	 1 1 9.53±0.01 1.8	x	10‐7	
0	 0	 1 2 15.81±0.03 	
1	 0	 1 0 5.81±0.08 1.9	x	10‐8	
1	 0	 2 0 10.12±0.09 	
1	 1	 1 0 10.01±0.1 	
1	 1	 1 1 17.66±0.09 3.2	x	10‐7	
Aspartic	 0	 0	 1 1 9.68±0.01 3.9	x	10‐8	
0	 0	 1 2 13.35±0.01 	
1	 0	 1 0 4.63±0.04 2.9	x	10‐8	
1	 0	 2 0 7.75±0.07 	
1	 1	 1 0 9.12±0.07 2.3	x	10‐7	
Methionine	 0	 0	 1 1 9.10±0.01 8.9	x	10‐8	
0	 0	 1 2 11.08±0.03 	
1	 0	 1 0 3.82±0.01 3.8	x	10‐9	
1	 0	 2 0 7.22±0.07 	
1	 1	 2 0 8.09±0.08 3.1	x	10‐7	
CBDCA	 0	 0	 1	 1	 5.68±0.004	 1.3	x	10‐7	
0	 0	 1 2 8.80±0.006 	
1	 0	 1 0 2.68±0.05 2.9	x	10‐7	
1	 0	 2 0 3.98±0.07 	
1	 1	 1 0 7.87±0.08 5.6	x	10‐7	
Methylamine	 0	 0	 1	 1	 10.55±0.004	 8.9	x	10‐9	
1	 0	 1	 0	 3.59±0.04	 3.9	x	10‐6	
1	 0	 2 0 6.82±0.09 	
1	 1	 1 0 7.48±0.07 3.8	x	10‐7	
1	 1	 2 0 13.80±0.08 	
a	l,	p,	q	and	r	are	stoichiometric	coefficients	corresponding	to	Cd(II),	AMBI,	amino	acid	and	H+	respectively.	
b	Sum	of	square	of	residuals.		
	
This	 may	 reveal	 that	 aspartic	 acid	 coordinates	 via	 the	
amino	and	one	carboxylate	group.		
Histamine	 has	 two	 binding	 sites	 via	 imidazole	 and	 amino	
group.	Histamine	has	been	shown	to	form	protonated	complex	
species	 (1111).	 The	 acid	 dissociation	 constants	 of	 the	
protonated	species	is	given	by	the	equation	(4)	[30].	
	
 ( ) ( )( ) ( )( )( ) ( )( )log ‐ log
H Cd AMBI Cd AMBI
Cd AMBI L Cd AMBI L H Cd AMBI LpK K K 	 (4)		
	
The	 pKa	 value	 for	 the	 histamine	 complex	 is	 (pKa	 =	 7.74),	
being	lower	than	that	of	the	protonated	amino	group	(NH3+)	in	
histamine	 ligand	 (pKa	 =	 9.85)	 considering	 the	 increase	 in	
acidity	due	to	complex	formation.	This	reveals	that	the	proton	
in	 the	 protonated	 complex	 would	 be	 located	 mainly	 on	 the	
amino	group.		
Evaluation	 of	 the	 concentration	 distribution	 of	 various	
complex	 species	 as	 a	 function	 of	 pH	 provides	 a	 useful	
description	of	metal	ion	binding	in	the	biological	system.	In	all	
species	 distribution	 curves	 the	 concentration	 of	 the	 formed	
complex	 increases	 with	 increasing	 pH;	 thus	 making	 the	
complex	formation	more	favored	in	the	physiological	pH	range,	
whereas	 at	 higher	 value	 than	 the	 physiological	 pH,	 hydroxo	
species	predominates.	
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Table	2.	Stability	constants	of	binary	and	ternary	species	in	the	Cd(II)‐AMBI‐	peptide	systems	25	oC	and	0.1	mol.dm‐3	ionic	strength	using	NaNO3.	
System	 l	 p	 q	 ra	 Log	β		 S	b	
Glycinamide	 0	 0	 1 1 7.60±0.01 8.5	x	10‐8	
1	 0	 1 0 2.65±0.07 1.4	x	10‐7	
1	 0	 2	 0	 4.88±0.05	 	
1	 1	 1	 0	 8.88±0.09	 2.8	x	10‐6	
1	 1	 1	 ‐1	 0.24±0.09	 	
Glycylglycine	 0	 0	 1 1 7.99±0.006 4.5	x	10‐8	
0	 0	 1 2 11.27±0.01 	
1	 0	 1 0 2.89±0.02 1.7	x	10‐8	
1	 0	 2	 0	 5.36	±0.05	 	
1	 1	 1	 0	 9.07±0.08	 5.3	x	10‐7	
1	 1	 1	 ‐1	 0.19±0.09	 	
Glutamine	 0	 0	 1 1 8.95±0.008 4.5	x	10‐8	
1	 0	 1 0 3.47±0.06 3.4	x	10‐7	
1	 0	 2 0 6.51±0.04 	
1	 1	 1	 0	 9.36±0.06	 1.2	x	10‐6	
1	 1	 1	 ‐1	 0.21±0.01	 	
a	l,	p,	q	and	r	are	stoichiometric	coefficients	corresponding	to	Cd(II),	AMBI,	peptide	ligand	and	H+,	respectively.	
b	Sum	of	square	of	residuals.		
	
	
The	concentration	distribution	diagram	of	Cd‐AMBI‐alanine	
taken	as	a	representative	example	of	amino	acids,	 is	shown	in	
Figure	 2,	 the	 binary	 complexes	 Cd(AMBI)	 and	 Cd(AMBI)2	 are	
formed	with	maximum	percent	of	45%	and	20%	at	pH	=	7	and	
7.6	 respectively.	 The	 mixed	 ligand	 species	 [Cd(AMBI)Ala]	
(1110)	starts	to	form	at	pH	7.0	and	with	increasing	of	pH,	its	
concentration	increases	reaching	the	maximum	of	60	%	at	pH	=	
10.	
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Figure	2.	Concentration	distribution	of	various	species	as	a	function	of	pH	in	
the	 Cd‐AMBI‐Alanine	 system	 at	 concentration	 of	 1.25x10‐3	 mol.dm‐3	 for	
Cd(II),	AMBI	and	alanine,	I	=	0.1	mol.dm‐3	(NaNO3)	and	T	=	25	±	0.1	oC).	
	
	
3.2.2.	Ternary	complex	formation	equilibria	involving	
amides	
	
Ternary	 complex	 formation	 of	 amides	 proceeds	 also	
through	 simultaneous	 mechanism.	 Cd(AMBI)(L)	 and	
Cd(AMBI)(LH‐1)	species	detected	and	their	formation	constants	
are	 given	 in	 Table	 2.	 The	 amide	 may	 form	 the	 Cd(AMBI)(L)	
complex	 by	 coordination	 through	 the	 amine	 and	 carbonyl	
groups.	 On	 increasing	 the	 pH,	 the	 coordination	 sites	 should	
switch	 from	carbonyl	oxygen	to	amide	nitrogen.	Such	changes	
in	 coordination	 centers	 are	 now	 well	 documented	 [31].	 The	
amide	groups	undergo	deprotonation	and	 the	Cd(AMBI)(LH‐1)	
complexes	 are	 formed.	 The	 pKH	 values	 are	 calculated	 by	 the	
equation	(5)	[30].	
	
pKH	=	Log	1110	‐	Log	111‐1		 	 	 	 (5)	
		
The	pKH	values	of	the	amide	complexes	are	8.64,	8.88	and	
9.12	for	glycinamide,	glycylglycine	and	glutamine	respectively.	
It	 is	 noteworthy	 that	 the	 pKH	 for	 the	 glycinamide	 complex	 is	
lower	 than	 the	 pKHs	 of	 other	 amides,	 this	 signifies	 that	 the	
more	 bulky	 substituent	 group	 on	 the	 amides	 may	 serve	 to	
hinder	 the	 structural	 change	 in	 going	 from	 protonated	 to	
deprotonated	complexes.	The	pKH	of	the	glutamine	complex,	on	
the	 other	 hand	 is	 exceptionally	 relatively	 higher	 than	 the	
others.	 This	 is	 due	 to	 the	 formation	 of	 a	 seven	 membered	
chelate	 ring,	which	would	 be	more	 strained	 and	 less	 favored.	
Therefore,	 under	 physiological	 conditions	 (pH	 =	 7.4),	
glutamine	 would	 coordinate	 in	 its	 protonated	 form,	 whereas	
glycinamide	would	preferably	 coordinate	 in	 the	 deprotonated	
form.	The	speciation	diagram	of	glycinamide	complex	 is	given	
in	 Figure	 3.	 The	 mixed	 ligand	 species	 [Cd(AMBI)L]	 (1110)	
starts	 to	 form	 at	 pH	 =	 5.2	 and	 with	 increasing	 pH,	 its	
concentration	increases	reaching	the	maximum	of	62%	at	pH	=	
7.6.	 Further	 increase	 of	 pH	 is	 accompanied	 by	 a	 decrease	 in	
[Cd(AMBI)L]	(1110)	complex	concentration	and	an	increase	of	
[Cd(AMBI)LH‐1]	 (111‐1)	 complex	 concentration	 reaching	 a	
maximum	of	98%	at	pH	=	10.8.	
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Figure	3.	Concentration	distribution	of	various	species	as	a	function	of	pH	in	
the	Cd‐AMBI‐Glycinamide	system	at	concentration	of	1.25x10‐3	mol.dm‐3	for	
Cd(II),	AMBI	and	glycinamide,	I	=	0.1	mol.dm‐3	(NaNO3)	and	T	=	25	 0.1	oC).
	
3.3.	Comparison	of	the	stability	constant	of	the	ternary	
complexes	with	those	of	the	binary	complexes	
	
The	relative	stabilities	of	the	species	and	the	magnitudes	of	
interactions	 involved	 can	 be	 understood	 by	 comparing	 the	
stepwise	 formation	 constants.	 The	 formation	 constants	 of	 Cd‐
AMBI	 and	 Cd‐L	 (L	 =	 Glycine	 as	 a	 representative	 example	 of	
amino	acids)	are	used	for	comparison	as	shown	in	Scheme	3.		
Hence,	 it	seems	therefore	 to	be	of	considerable	 interest	 to	
discuss	 the	 parameters	 generally	 used	 for	 indicating	 the	
stabilization	of	the	mixed	complexes	with	respect	to	the	binary	
ones	namely:	
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Table	3.	Evaluated	values	of	Log	β;	ΔLog	K,	ΔLog	β;	Log	X	for	the	formation	of	the	ternary	complexes	[Cd(AMBI)(L)]	and	ΔR	for	the	side	chains	of	amino	acid	
ligands	at	25	oC	and	0.1	mol.dm‐3	ionic	strength	using	NaNO3.	
Ligand	 Log	β1110	(Exp.)	 Log	βStat.	a	(Calcd.)	 	Log	β	b	 	Log	K	c	 Log	X	d	 R	
Glycine	 9.20	 8.58	 0.62	 0.24	 1.85	 ‐	
Alanine	 9.01	 8.38	 0.63	 0.26	 1.86	 0.02	
Phenylalanine	 9.56	 8.08 1.48 1.02	 3.57	 0.78
Valine	 9.11	 8.10	 1.01	 0.60	 2.63	 0.36	
Threonine	 8.52	 8.22 0.30 ‐0.06	 1.21	 ‐0.30
Histidine	 10.01	 9.63 0.38 ‐0.36	 1.36	 ‐0.60
Aspartic	 9.12	 8.45 0.67 ‐0.07	 1.95	 ‐0.31
Histamine	 10.15	 8.53 1.62 0.84	 3.85	 0.60
a	Log	β	stat	=	Log	2	+1/2	Log	β1020	+	1/2	Log	β1200	
b	Δ	Log	β	=	Log	β1110	‐	Log	βstat	
c	Δ	Log	K	=	Log	β1110	‐	Log	β1100	‐	Log	β1010	
d	Log	X	=	2	Log	β1110	‐	Log	β1020	‐	Log	β1200	
	
	
Table	4.	Evaluated	values	of	Log	β;	ΔLog	K,	ΔLog	β;	Log	X	for	the	formation	of	the	ternary	complexes	[Cd(AMBI)(L)]	at	25	oC	and	0.1	mol.dm‐3	ionic	strength	using	
NaNO3.	
Ligand	(L)	 Log	β1110	(Exp.)	 Log	βStat.	a	(Calcd.)  Log	β	b 	Log	K	c	 Log	X	d
Glycinamide	 8.88	 7.01 1.87 1.67	 4.34
Glycylglycine	 9.07	 7.25 1.82 1.62	 4.24
Glutamine	 9.36	 7.83 1.53 1.33	 3.67
a	Log	β	stat	=	Log	2	+1/2	Log	β1020	+	1/2	Log	β1200	
b	Δ	Log	β	=	Log	β1110	‐	Log	βstat	
c	Δ	Log	K	=	Log	β1110	‐	Log	β1100	‐	Log	β1010	
d	Log	X	=	2	Log	β1110	‐	Log	β1020	‐	Log	β1200	
	
	
Cd
Cd-AMBI
Cd-Gly
Cd(AMBI)2
Cd(Gly)2
Cd(AMBI)(Gly)
4.56
4.38
3.64
3.98
4.64
4.82
 
	
Scheme	3	
	
	(1)	 ΔLog	 K,	 the	 difference	 between	 the	 stabilities	 of	 the	
binary	 and	mixed	 complexes.	 One	 expects	 to	 obtain	 negative	
values	 for	ΔLog10	K	 (Tables	3	and	4),	since	more	coordination	
positions	 are	 available	 for	 the	 bonding	 of	 ligand	 (L)	 in	 the	
binary	 than	 in	 the	 ternary	complexes.	According	 to	Sigel	 [32],	
the	 relative	 stability	 of	 a	 ternary	 complex	 Cd(AMBI)L	 (1110)	
compared	 to	 its	 binary	 complex	 Cd(AMBI)	 (1100)	 or	 Cd(L)	
(1010)	 can	 be	 expressed	 quantitatively	 by	 equations	 (7)	 and	
(8).		
	
Cd(AMBI)	+	Cd(L)	⇌	Cd(AMBI)(L)	+	Cd		 	 (6)	
	
Δ	Log	K	 Cd(AMBI)L	=	Log	βCd(AMBI)(L)	–	 (Log	β	 Cd(AMBI)	+	Log	β	 Cd(L))	
	 	 	 	 	 	 (7)	
	
The		Log	K	value	for	protonated	ternary	complex	is	given	
by	equation	(8).		
	
	Log	K	=	Log	1111	‐	Log	1100	‐	Log	1011		 	 (8)	
	
The		Log	K	values	for	ternary	complex	of	phenylalanine	is	
more	 positive	 than	 that	 of	 alanine.	 This	may	 be	 explained	 on	
the	premise	 that	 the	noncoordinating	aromatic	side	groups	of	
pheylalanine	 can	 approach	 the	 aromatic	moiety	 of	 AMBI	 and	
exert	 a	 stacking	 interaction	 as	 shown	 in	 structure	 (I)	 of	
[Cd(AMBI)Phe]	complex,	since	the	presence	of	an	aromatic	ring	
above	 the	 Cd(II)	 coordination	 plane	 is	 probably	 essential	 for	
preferential	formation	of	ternary	complexes	(Scheme	4).	
	
 
	
Scheme	4	
	
	
(2)	 Log	 X,	 the	 quantitative	 stabilization	 of	 ternary	
complexes	 can	 be	 expressed	 in	 terms	 of	 their	
disproportionation	 constant	 X.	 The	 values	 of	 Log	 X	 (Tables	 3	
and	 4)	 can	 be	 calculated	 by	 equations	 (9‐11)	 for	 Cd(AMBI)L	
complexes.	
	
Cd(AMBI)2	+	Cd(L)2	⇌	2	Cd(AMBI)(L)		 	 	 (9)	
	
2
Cd(AMBI)(L)
2 2
[Cd(AMBI)(L)]
X =
[Cd(AMBI) ][Cd(L) ]
	 	 	 (10)	
	
Log	X	Cd(AMBI)(L)	=	2	Log	βCd(AMBI)(L)	–	(Log	βCd(AMBI)2	+	Log	βCd(L)2)	
	 	 	 	 	 	 (11)		
	
The	value	for	Log	X	expected	from	statistical	reasons	is	+ 0.6	
[33]	 for	 all	 geometries.	The	values	of	Log	X	 in	Table	3	 are	>>	
0.6,	 indicating	marked	 stabilities	 of	 the	 ternary	 complexes.	 A	
heteroaromatic	 N	 base	 is	 essential	 for	 the	 high	 stability	 of	 a	
ternary	complex	[33,34].	This	was	attributed	to	π	back‐bonding	
from	 the	metal	 ion	 to	 the	 aromatic	 ligand	 [34‐37].	 The	 same	
finding	 was	 obtained	 for	 the	 ternary	 complexes	 formed	 by	
Cu(Pyrocatecholate)	 with	 2‐picolylamine,	 bipyridyl	 and	 2‐
aminomethylbenzimidazole	[38].	
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Table	5.	Effect	of	temperature	on	the	formation	constants	of	Cd(AMBI)‐Glycine	complex	at	I	=	0.1	mol.dm‐3	NaNO3.	
System	 T	(oC)	 l	 p	 q	 r	a	 Log		 S	b	
Cd‐AMBI‐Glycine	 20	 0	 1	 0	 1	 7.95±0.01	 2.1	x	10‐7	
0	 1	 0	 2	 11.23±0.02	 	
0 0 1 1 9.86±0.03 3.2	x	10‐8	
0 0 1 2 12.17±0.05 	
1 1 0 0 4.61±0.03 5.7	x	10‐7	
1 2 0 0 8.64±0.06 	
1 0 1 0 4.44±0.03 3.5	x	10‐8	
1 0 2 0 8.14±0.07 5.9	x	10‐7	
1 1 1 0 9.34	±0.08 	
Cd‐AMBI‐Glycine	 25	 0 1 0 1 7.86±0.04 4.8	x	10‐7	
0 1 0 2 11.11±0.05 	
0 0 1 1 9.71±0.02	 3.1	x	10‐7	
0 0 1 2 11.99±0.03 	
1 1 0 0 4.56±0.07 1.6	x	10‐7	
1 2 0 0 8.54±0.06 	
1	 0	 1	 0	 4.38±0.01	 2.2	x	10‐8	
1	 0	 2	 0	 8.02±0.02	 	
1	 1	 1	 0	 9.20±0.09	 2.1	x	10‐6	
Cd‐AMBI‐Glycine	 30	 0 1 0 1 7.78±0.06 1.8	x	10‐7	
0	 1	 0	 2	 11.01±0.08	 	
0 0 1 1 9.58±0.03	 5.1	x	10‐7	
0	 0	 1	 2	 11.83±0.05	 	
1	 1	 0	 0	 4.50±0.05	 3.6	x	10‐7	
1	 2	 0	 0	 8.43±0.08	 	
1 0 1 0 4.31±0.04 4.9	x	10‐7	
1 0 2 0 7.90±0.06 	
1 1 1 0 9.07±0.07 8.1	x	10‐7	
Cd‐AMBI‐Glycine	 35	 0	 1	 0	 1	 7.70±0.03	 3.5	x	10‐7	
0	 1	 0	 2	 10.90±0.05	 	
0	 0	 1	 1	 9.43±0.03		 7.1	x	10‐8	
0 0 1 2 11.65±0.04 	
1 1 0 0 4.44±0.05 3.6	x	10‐7	
1 2 0 0 8.32±0.05 	
1 0 1 0 4.25±0.03 2.2	x	10‐7	
1 0 2 0 7.78±0.04 	
1 1 1 0 8.94±0.08 9.2	x	10‐7	
a	l,	p,	q	and	r	are	stoichiometric	coefficients	corresponding	to	Cd(II),	AMBI,	Glycine	and	H+,	respectively.	
b	Sum	of	square	of	residuals.	
	
	
	(3)	Δ	Log	β,	 the	 stabilization	 constant	which	 results	 from	
the	difference	of	the	stability	constant	measured	for	the	mixed	
complex	 and	 that	 calculated	 from	 statistical	 grounds.	 The	
stability	 of	 the	 ternary	 complexes	 investigated	 can	 also	 be	
calculated	 using	 a	 statistical	 method	 [39]	 according	 to	 the	
equation	(12).	
	
Log	βstat	=	Log	2	+1/2	Log	β1020	+	1/2	Log	β1200		 	 (12)	
	
The	 values	 of	 Log	 βstat	 for	 the	 mixed	 ligand	 complexes	
detected	 in	 this	study	are	 shown	 in	Tables	3	and	4.	The	 large	
differences	of	Δ	Log	β	values	(Log	β1110	‐	Log	βstat)	indicate	that	
the	Cd(AMBI)L	system	is	more	stable	than	both	Cd(AMBI)2	and	
Cd(L)2.	
	
3.4.	ΔR	of	amino	acids	
	
In	 order	 to	 evaluate	 the	 effect	 of	 the	 side	 chains	 of	 the	
amino	 acid	 ligands	 on	 their	 ability	 to	 coordinate	 with	 the	
binary	Cd‐AMBI,	the	parameter	ΔR,	defined	by	equation	(13),	is	
reasonably	considered	[40],		
	
	ΔR	=	Log	K	Cd(AMBI)(L)	‐	Log	K	Cd(AMBI)(gly)	=		
										(Log	 β1110(L)	 ‐	 Log	 β1110(gly))	 ‐	 (Log	 β1010(L)	 ‐	 Log	 β1010(gly))	
	 	 	 	 	 	 (13)	
	
Using	ΔR	only	the	effect	of	the	side	chains	can	be	extracted,	
referring	 to	 the	 hydrogen	 of	 glycine.	 The	 parameter	 ΔR	
represents	 the	 Logarithm	 of	 the	 equilibrium	 constant	 of	 the	
apparent	ligand	exchange	reactions	shown	by	equation	(14),		
	
Cd(AMBI)(gly)	+	Cd(L)	⇌	Cd(AMBI)(L)	+	Cd(gly)		 (14)	
	
	
By	 viewing	 the	 values	 of	 ΔR	 listed	 in	 Table	 3,	 it	 is	 quite	
evident	 that	 the	 aromatic	 side	 chains	 have	 a	 large	 stability‐
enhancing	 effect	 compared	with	 the	 hydrogen	 of	 glycine,	 also	
the	 C‐alkyl	 side	 chains	 show	 a	 stability‐enhancing	 effect.	 This	
fact	indicates	that		
a) A	 ring	 stacking	 interaction	 with	 the	 aromatic	 side	
chains.		
b) A	 sort	 of	 hydrophobic	 intramolecular	 interaction	
operating	 between	 the	 hydrophobic	 moiety	 of	 AMBI	
and	 the	 alkyl	 groups	 in	 aqueous	 solutions.	 Such	 a	
hydrophobic	 interaction	 has	 been	 reported	 for	 the	
ternary	 complexes	 including	phen	 or	Bipy	 and	C‐alkyl	
substituted	 amino	 acids	 [41,42].	 Since	 the	
hydrophobicity	 of	 the	 aromatic	 amino	 acids	 is	 large	
compared	 with	 that	 of	 the	 alkyl	 side	 groups	 [42,43].	
This	 probably	 the	 reason	 why	 the	 ternary	 complexes	
containing	 AMBI	 and	 the	 aromatic	 amino	 acids	 show	
high	stabilities.		
c) The	 extent	 of	 intramolecular	 ligand‐ligand	 interaction	
decreases	 in	 the	 series	 aromatic‐aromatic	 >	 aromatic‐
aliphatic	>	aliphatic‐aliphatic.	
d) Hydrophobic	 interactions	are	very	 important	 in	amino	
acid	complexes	[21].		
	
3.5.	Effect	of	temperature		
	
The	 values	 obtained	 for	 the	 thermodynamic	 parameters	
ΔHo,	ΔSo	and	ΔGo,	associated	with	the	protonation	of	AMBI,	Gly	
and	 its	complex	formation	with	Cd(II)	species	were	calculated	
from	 the	 temperature	dependence	of	 the	data	 in	Table	5.	ΔHo	
and	ΔSo	were	obtained	by	 linear	 least	square	fit	of	 ln	K	versus	
1/T	(ln	K	=	‐	ΔHo/RT	+	ΔSo/R)	leading	to	an	intercept	ΔSo/R	and	
a	slope	–ΔHo/R,	where	K	is	the	equilibrium	constant.		
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Table	6.	Thermodynamic	 parameters	 for	 protonation	 and	 complex	 formation	 equilibria	 of	 [Cd(AMBI)(Gly)]	 system	 in	 aqueous	 solution	 at	 I	 =	 0.1	mol.dm‐3	
NaNO3*.	
T	(oC)	 Log	K1	 ∆G1o	 ∆Ho	 ∆S1o Log	K2 ∆G2o ∆Ho	 ∆S2o
AMBI	
20	 7.95	 ‐44.83	 ‐28.68	 54.19	 3.28	 ‐18.73	 ‐12.44	 20.68	
25	 7.86	 3.25
30	 7.78	 3.23
35	 7.70	 3.20	
Cd‐AMBI	
T	(oC)	 Log	K1	 Log	K2	 Log	K1	–	Log	K2	 ∆G1o	 ∆H1o	 ∆G2o	 ∆H2o	 ∆S1o	 ∆S2o	
20	 4.61	 4.03	 0.58	 ‐26.10 ‐19.66
	
‐20.47 ‐17.28	
	
21.62	 10.72
25	 4.56	 3.98	 0.58	
25	 4.50	 3.93	 0.57	
35	 4.44	 3.88	 0.56	
Gly	
T	(oC)	 Log	K1	 ∆G1o	 ∆H1o	 ∆S1o	 Log	K2	 ∆G2o		 ∆H2o	 ∆S2o	
20	 9.86	 ‐55.40	 ‐49.07	
	
21.25
	
2.31 ‐13.00 ‐10.36	 8.85	
25	 9.71	 2.28
25	 9.58	 2.25	
35	 9.43	 2.22
Cd‐Gly	
T	(oC)	 Log	K1	 Log	K2	 Log	K1	–	Log	K2 ∆G1o ∆H1o ∆G2o ∆H2o	 ∆S1o	 ∆S2o
20	 4.44	 3.70	 0.79	 ‐25.02 ‐22.12 ‐20.81 ‐19.35	 9.57	 4.80
25	 4.38	 3.64	 0.74	 	
30	 4.31	 3.59	 0.68	 	
35	 4.25	 3.53	 0.63	 	
Cd‐AMBI‐Gly	
T	(oC)	 Log	K	 	∆Go		 ∆Ho	 ∆So
20	 9.34	 ‐52.47	 ‐45.97	 21.83
25	 9.20	 	 	
30	 9.07	 	 	
35	 8.94	 	 	
*	∆Go,	kJ/mol;	∆Ho,	kJ/mol	and	∆So,	J.K/mol.		
	
	
	The	 thermodynamic	 parameters	 ΔHo,	 ΔSo	 and	 ΔGo	 were	
given	 in	 Table	 6	 and	 the	 linear	 relation	 for	 Cd(AMBI)‐Gly	
complex	between	Log	K	and	1/T	is	given	in	Figure	4.	The	main	
conclusions	from	the	data	can	be	summarized	as	follows.		
	(1)	The	protonation	reactions	of	AMBI	can	be	represented	
by	equations	(15)	and	(16):		
	
	L	+	H+	⇌	HL+		 K1	=	[HL+]/[L][H+]		 	 	 (15)	
	 	
HL+	+	H+	⇌	H2L2+		 K2	=	[H2L2+]/[HL+][H+]		 	 (16)	
		
(2)	The	protonation	reactions	of	glycine	can	be	represented	
by	equations	(17)	and	(18):		
	
	L‐	+	H+	⇌	HL	K1	=	[HL+]/[L][H+]		 	 	 (17)	
	
HL	+	H+	⇌	H2L+	K2	=	[H2L2+]/[HL+][H+]		 	 	 (18)	
	
The	 thermodynamic	 processes	 accompanying	 the	
protonation	reactions	are:	
a) the	 neutralization	 reaction,	 which	 is	 an	 exothermic	
process;	
b) desolvation	of	ions,	which	is	an	endothermic	process;	
c) the	 change	 in	 the	 configuration	 and	 the	 arrangements	
of	the	hydrogen	bonds	around	the	free	and	protonated	
ligands.	
(3)	The	Log	KH	values	for	the	protonation	reaction	of	AMBI	
and	 glycine	 as	 given	 in	 equations	 15‐18	 decrease	 with	
increasing	 temperature.	 This	 means	 that,	 the	 dissociation	
constants	 increase	 with	 the	 increase	 of	 the	 temperature	
revealing	 that	 their	 acidity	 increase	 with	 increasing	
temperature	[44]	
(4)	A	negative	value	of	∆Ho	 for	 the	protonation	process	of	
both	 ligands	 indicates	 that	 their	 association	 process	 is	
accompanied	 by	 a	 release	 of	 heat	 and	 the	 process	 is	
exothermic.		
(5)	 The	 protonation	 reaction	 of	 the	 ligands	 has	 positive	
entropy;	 this	may	 be	 due	 to	 increased	 disorder	 as	 a	 result	 of	
desolvation	 processes	 and	 the	 breaking	 of	 hydrogen	 bonds.	
Moreover,	 the	 second	protonation	processes	are	accompanied	
by	less	positive	entropy	than	the	first	one.	
The	stepwise	stability	constants	of	the	Cd‐AMBI	and	Cd‐Gly	
complexes	 formed	 at	 different	 temperatures	 were	 calculated	
and	 the	 average	 values	 are	 included	 in	 Table	 6.	 These	 values	
decrease	 with	 increasing	 temperature	 (Figure	 4),	 confirming	
that	 the	 complexation	 process	 is	 more	 favorable	 at	 lower	
temperatures.	From	these	results	the	following	conclusions	can	
be	made.	
1. All	 values	 of	 ∆Go	 for	 complexation	 are	 negative,	
indicating	 that	 the	 chelation	 process	 proceeds	
spontaneously.	
2. The	 negative	 values	 of	 ∆Ho	 show	 that	 the	 chelation	
process	is	exothermic,	indicating	that	the	complexation	
reactions	 are	 favored	 at	 low	 temperatures.	
Furthermore,	 when	 a	 coordinate	 bond	 between	 the	
ligand	and	the	metal	ion	is	formed,	the	electron	density	
on	 the	metal	 ion	generally	 increases.	Consequently,	 its	
affinity	for	a	subsequent	ligand	decreases,	leading	to	an	
increase	in	∆Go	and	∆Ho	of	complexation.	
3. It	is	generally	noted	that	‐∆G1o	>	‐∆G2o	and	‐∆H1o	>	‐∆H2o.	
This	 may	 be	 attributed	 to	 the	 steric	 hinderance	
produced	by	the	entrance	of	a	second	ligand.		
4. The	 ∆So	 values	 for	 all	 investigated	 complexes	 are	
positive,	 indicating	 that	 the	 increase	 in	entropy	by	 the	
release	 of	 bound	 solvent	 molecules	 on	 chelation	 is	
greater	 than	 the	decrease	 resulting	 from	 the	chelation	
process	 itself.	 It	 occurs	 because	 the	 solvent	molecules	
arranged	 in	 an	 orderly	 fashion	 around	 the	 ligand	 and	
the	 metal	 ion	 has	 acquired	 a	 more	 random	
configuration	on	chelation.		
	
4.	Conclusions	
	
The	 present	 investigation	 describes	 the	 formation	
equilibria	 of	 Cd(II)	 complexes	 involving	 2‐(aminomethyl)‐
benzimidazole	 and	 some	 ligands	 of	 biological	 significance.	 In	
combination	 of	 stability	 constants	 data	 of	 such	 Cd(II)	
complexes	with	amino	acids	and	peptides,	it	would	be	possible	
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to	calculate	the	equilibrium	distribution	of	the	metal	species	in	
biological	 fluids	 where	 most	 types	 of	 ligands	 are	 present	
simultaneously.	 This	 would	 form	 a	 clear	 basis	 for	
understanding	the	mode	of	action	of	such	metal	species	under	
physiological	 conditions.	 From	 the	 above	 results	 it	 may	 be	
concluded	 that	 ternary	 complex	 formation	 proceeds	 through	
simultaneous	 mechanism.	 Amino	 acids	 form	 highly	 stable	
complexes;	 the	 substituent	 on	 the	 α‐carbon	 atom	 has	 a	
significant	effect	on	the	stability	of	the	formed	complex.	The	β‐
alcoholate	group	in	the	side	chain	of	the	amino	acid	threonine	
has	been	found	to	play	an	essential	role	in	the	functionating	of	a	
number	 of	 proteolytic	 enzymes,	 e.g.	 chymotrypsin	 and	
subtilisin	[Cd(AMBI)LH‐1]	is	formed	through	induced	ionization	
of	 the	alcohol	group	of	 threonine	under	complex	 formation	as	
reported	in	the	literature	[18,21,23].	The	present	study	shows	
clearly	 that	 the	 deprotonation	 of	 the	 peptide	 bond	 was	
promoted	under	complex	formation.	Also,	the	slight	difference	
in	 the	 side	 chain	 of	 the	 peptides	 seems	 to	 produce	 dramatic	
differences	 in	 their	 behavior	 on	 complexation	 process.	 The	
more	positive	Log	X	and	 less	negative	ΔLog	K	 is	 attributed	 to	
the	extra	stability	of	the	ternary	complexes.	From	the	values	of	
the	 thermodynamic	parameters,	 the	 following	points	 could	be	
abstracted:	
a) Acidity	of	AMBI	increases	with	increasing	temperature.	
b) The	values	of	Log	K1‐Log	K2	are	positive,	indicating	that	
the	 coordination	 of	 the	 first	 ligand	 molecule	 to	 the	
metal	 ion	 is	 more	 favorable	 than	 the	 bonding	 to	 the	
second	one.	
c) The	 negative	 free	 energy	 and	 enthalpy	 changes	 of	 all	
the	complexes	indicated	a	spontaneous	and	exothermic	
nature	of	complexation	reactions.		
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Figure	4.	Van,t	Hoff	plot	for	[Cd(AMBI)(Gly)]	complex.
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